TSX Ends On Firm Note As Technology, Financials Shares Rise

RTTNews | 345 hari yang lalu
TSX Ends On Firm Note As Technology, Financials Shares Rise

(RTTNews) - The Canadian market ended on a firm note on Friday, aided by strong gains in technology, consumer discretionary and financials sectors.

The mood in the market remained fairly positive amid signs of progress in U.S. debt ceiling deal negotiations.

The benchmark S&P/TSX Composite Index ended with a gain of 146.23 points or 0.74% at 19,920.31. The index scaled a low of 19,832.78 and a high of 19,944.09 intraday. The index shed 2.1% in the week.

The Capped Information Technology surged nearly 2%. Celestica Inc (CLS.TO) soared 10.3%. Hut 8 Mining Corp (HUT.TO) rallied nearly 6%. Coveo Solutions (CVO.TO), Converge Technology Solutions (CTS.TO), Bitfarms (BITF.TO), Kinaxis (KXS.TO), Open Text Corporation (OTEX.TO), Constellation Software (CSU.TO), Enghouse Systems (ENGH.TO), Quarterhill (QTRH.TO) and Docebo Inc (DCBO.TO) gained 1.5 to 4.3%.

Consumer discretionary stocks Spin Mater Corp (TOY.TO), Dollarama Inc (DOL.TO), Gildan Activewear (GIL.TO) and Magna International (MG.TO) advanced 1.5 to 2%.

Among financials, Fairfax Financial Holdings (FFH.TO) climbed more than 3%. Bank of Montreal (BMO.TO), Nuvei Corp (NVEI.TO), Manulife Financial (MFC.TO), goeasy (GSY.TO), Canadian Imperial Bank of Commerce (CM.TO) and Royal Bank of Canada (RY.TO) ended higher by 1.3 to 1.6%.

Healthcare stock Tilray Inc (TLRY.TO) tanked 20.5% after the company said it would be offering a 5.2% convertible senior note offering due in 2027 and announced pricing of $150 million of that.

On the economic front, preliminary data from Statistics Canada showed wholesale sales in Canada increased 1.6% month-over-month in April 2023, after a 0.1% drop in March.

read more
Cohen & Co. Swings To Net Profit In Q1; Revenues Soar

Cohen & Co. Swings To Net Profit In Q1; Revenues Soar

Financial services company Cohen & Co. Inc. (COHN) reported Monday net income attributable to Company for the first quarter of $2.02 million or $1.28 per share, compared to a net loss of $2.64 million or $1.77 per share in the prior-year quarter.
RTTNews | 4h 25menit yang lalu
Eurozone Private Sector Growth Accelerates In April

Eurozone Private Sector Growth Accelerates In April

The euro area private sector growth accelerated to an 11-month high in April driven by the service sector, final survey results from S&P Global showed on Monday. The HCOB composite output index rose to 51.7 in April from 50.3 in the previous month. The flash estimate was 51.4.
RTTNews | 4h 35menit yang lalu
TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

Biotechnology company TC BioPharm (Holdings) plc (TCBP) announced Monday the execution of a non-binding letter of intent to acquire a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors.
RTTNews | 4h 56menit yang lalu
Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Squibb Co. (BMY) announced Monday that the European Medicines Agency (EMA) has validated its Type II variation application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).
RTTNews | 5h 36menit yang lalu
Bay Street Likely To Open On Firm Note

Bay Street Likely To Open On Firm Note

Higher Canadian and U.S. futures, and rising crude oil and bullion prices point to a positive start on Bay Street Monday morning. Optimism about rate cuts by the Fed and several central banks in Europe is also expected to aid market's rise.
RTTNews | 5h 40menit yang lalu
BioNTech Slips To Loss In Q1

BioNTech Slips To Loss In Q1

Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a net loss of 315.1 million euros or 1.31 euros per share for the first quarter, compared to net profit of 502.2 million euros or 2.05 euros per share in the prior-year quarter.
RTTNews | 6h 42menit yang lalu